Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
From MaRDI portal
(Redirected from Publication:856299)
Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
Recommendations
Cites work
- scientific article; zbMATH DE number 3984436 (Why is no real title available?)
- scientific article; zbMATH DE number 3474804 (Why is no real title available?)
- scientific article; zbMATH DE number 3638998 (Why is no real title available?)
- IX. On the problem of the most efficient tests of statistical hypotheses
- Optimum Character of the Sequential Probability Ratio Test
- Sequential Tests of Statistical Hypotheses
Cited in
(5)- Index policy for multiarmed bandit problem with dynamic risk measures
- Constructing strategies in strategic planning: a decision support evaluation model
- REAL OPTIONS AND THE EVALUATION OF RESEARCH AND DEVELOPEMENT PROJECTS IN THE PHARMACEUTICAL INDUSTRY : A CASE STUDY(Special Issue on Theory, Methodology and Applications in Financial Engneering)
- Genetic algorithm-based multi-criteria project portfolio selection
- Evaluating pharmaceutical R\&D under technical and economic uncertainty
This page was built for publication: Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q856299)